Enter a Ticker
Type any US-listed stock ticker. That's all we need. No documents, no URLs, no uploads — we go and find the data ourselves from primary sources so you don't have to hand us anything that could be wrong, outdated, or misleading.
Why ticker only? Because we pull directly from SEC EDGAR, FINRA, and regulatory databases. Starting from primary sources means every finding is traceable. Starting from a document you provide means we're only as reliable as what you gave us.
We pull directly from SEC EDGAR, FINRA, regulatory databases, and verified news sources.
We Investigate
Our engine identifies the company type — SPAC, biotech, tech, energy, fintech, or general public company — and pulls from the source databases most relevant to that industry. A biotech triggers ClinicalTrials.gov and FDA lookups. A SPAC triggers warrant dilution calculations and sponsor promote analysis. Every investigation uses the right tools for what it's actually investigating.
You Get the Report
A complete 7-pillar forensic investigation report, ready in about 60 seconds. Every finding links directly to its source — SEC filings, court records, regulatory databases, news articles. Nothing in the report is unverifiable.
STAY INFORMED
Filing alerts for stocks you follow.
After investigating a stock, turn on alerts from your My Investigations page. Each weekday morning, we check SEC EDGAR for new material filings on every stock you are monitoring. When something appears, a plain-English summary arrives in your inbox before the market opens.
Monitor up to 10 stocks at once. Toggle alerts on or off at any time from My Investigations. Included in all plans.
The 7-Pillar Investigation Framework
Every investigation covers the same seven dimensions. Nothing is skipped.
Who Benefits If You Buy?
ELEVATEDMaps exactly who profits if retail investors buy — and at what price they got in versus what you’re paying now. Calculates sponsor promote, PIPE discount, warrant dilution, and lock-up expiry dates using SEC proxy statements and S-4 filings.
Narrative vs. Evidence
REVIEW NEEDEDTakes the 5 most prominent investor claims and cross-references each one against independent public record — SEC filings of named partners, patent grant status, FDA approval databases, earnings guidance accuracy, and news archives. Verdict for each claim: Verified, Unverified, Exaggerated, or Contradicted.
Structural Legal Risks
HIGHSearches federal court records, SEC enforcement releases, state AG actions, FDA warning letters, and PCAOB auditor inspection reports. Flags going concern opinions, financial restatements, auditor changes, and active litigation with estimated exposure ranges.
Management Track Record
HIGHRuns every named executive and board member through FINRA BrokerCheck, SEC individual filing history, and news archives. Traces prior companies to their outcomes — acquired, failed, delisted, or under investigation. Calculates what percentage of prior public companies produced positive returns for shareholders.
Investor Cost Basis vs. Yours
ELEVATEDCalculates exactly what insiders, sponsors, and PIPE investors paid per share versus current market price. Shows full dilution math including warrants and shelf registrations. States plainly what market cap the company must reach for a retail investor buying today to break even.
Historical Analogues
WARNINGFinds 3–5 companies with the same business model, sector metrics, or path to market and shows what happened to their stock price. Sourced from Reuters, Bloomberg, and SEC archives — not stock screener opinions.
Bull Case Stress Test
MEDIUMStates the conditions under which this investment actually works — revenue growth required, margin improvement needed, regulatory approvals dependent on, capital raises that must not happen. Assesses each condition against industry base rates and current trajectory. The fairest possible hearing for the bull case, tested against real numbers.
Where We Look
Regulatory & Legal
- SEC EDGAR — All public filings: S-1, S-4, 10-K, 10-Q, 8-K, DEF 14A, Form 4, SC 13D/13G
- FINRA BrokerCheck — Executive and board member disciplinary history
- PCAOB — Auditor inspection reports and violations
- SEC Enforcement — Litigation releases and investigation notices
- Federal Court Records (PACER) — Active and historical litigation
Financial Data
- Yahoo Finance — Price history, market cap, short interest, institutional ownership
- Insider transaction filings — Who is buying, who is selling, and when
- Earnings history — Guidance accuracy and beat/miss record
News & Media
- Reuters, Bloomberg, WSJ, Financial Times — Verified financial reporting
- SEC News Digest — Regulatory actions
- Google News — 36-month archive search
- Excluded by policy: Reddit, StockTwits, SeekingAlpha, Motley Fool — sources that profit from pageviews on the ticker
Industry-Specific
- Biotech/Pharma — ClinicalTrials.gov, FDA warning letters, PubMed peer review
- Tech — USPTO patent database, Google Patents assignee search
- SPACs — SPAC Research, redemption rates, warrant dilution calculations, lock-up expiry tracking
- Mining/Energy — Permit databases, MSHA safety records, resource compliance
- Fintech/Crypto — FinCEN registration, state money transmitter licenses, CFTC/OCC enforcement
What The Stock Dossier Is Not
Not investment advice
The Stock Dossier investigates. You decide. We never tell you to buy, sell, or hold.
Not a Bloomberg terminal replacement
We surface public information efficiently. We are not a data terminal, portfolio manager, or trading platform.
Not infallible
AI-powered research can miss things. Every report includes sources so you can verify findings yourself. Always do your own additional research.
Not a guarantee
Even a perfect investigation can’t predict market outcomes. Past red flags don’t always mean future losses. Past clean bills don’t always mean future gains.
Not a stock screener
We don’t rank or filter stocks by financial metrics. We investigate specific companies you bring to us.
Not limited to SPACs or IPOs
Any publicly traded company, at any stage, in any sector, is investigable.
Not a document analyser
We don’t read files you provide. We go to primary sources ourselves so every finding is independently verifiable.